| Number of all screening smears (100%) |
158,041 |
156,141 |
155,751 |
158,668 |
141,651 |
156,415 |
155,625 |
150,270 |
151,245 |
152,161 |
| Satisfactory |
99.9% |
99.9% |
99.8% |
99.8% |
99.8% |
99.8% |
99.8% |
99.8% |
99.8% |
99.8% |
| Negative for intraepithelial lesion or malignancy |
90.6% |
90.4% |
90.1% |
89.1% |
89.0% |
89.7% |
89.6% |
89.9% |
89.0% |
89.8% |
| Non-neoplastic changes |
4.4% |
4.5% |
4.6% |
5.2% |
5.1% |
5.1% |
5.8% |
5.7% |
6.2% |
5.7% |
| Pathological changes |
4.9% |
4.9% |
5.1% |
5.5% |
5.7% |
5.1% |
4.4% |
4.2% |
4.6% |
4.3% |
| Pathological (squamous cells) |
4.8% |
4.8% |
5.0% |
5.4% |
5.6% |
5.0% |
4.3% |
4.1% |
4.5% |
4.2% |
| ASC-US |
2.9% |
2.9% |
3.0% |
3.3% |
3.5% |
3.1% |
2.7% |
2.5% |
3.0% |
2.8% |
| ASC-H |
0.3% |
0.3% |
0.3% |
0.3% |
0.3% |
0.2% |
0.3% |
0.3% |
0.2% |
0.2% |
| LSIL |
1.2% |
1.2% |
1.2% |
1.3% |
1.4% |
1.3% |
1.2% |
1.1% |
1.0% |
1.0% |
| HSIL |
0.5% |
0.4% |
0.4% |
0.5% |
0.4% |
0.3% |
0.2% |
0.2% |
0.2% |
0.2% |
| Squamous cell carcinoma |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
| Pathological (glandular cells) |
0.1% |
0.1% |
0.1% |
0.1% |
0.1% |
0.1% |
0.1% |
0.1% |
0.1% |
0.0% |
| AGC-NOS |
0.1% |
0.1% |
0.1% |
0.1% |
0.1% |
0.1% |
0.1% |
0.1% |
0.0% |
0.0% |
| AGC-favour neoplastic |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
| AIS |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
| Adenocarcinoma |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
| Other |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
| Suspicious cells, nonspecified |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
| Other malignant cells |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |